title: EMPA-REG: Glucose excretion and lipid mobilization - not storage - saves lives.
authors.affiliation: Department of Endocrinology, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. Electronic address: nils.bruun.joergensen.01@regionh.dk.
authors.forename: Nils Bruun
authors.initials: NB
authors.lastname: Jørgensen
authors.affiliation: Department of Endocrinology, Hvidovre Hospital, Kettegaards Alle 30, DK-2630, Hvidovre, Denmark.
authors.forename: Jens
authors.initials: J
authors.lastname: Pedersen
authors.affiliation: Department of Endocrinology, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
authors.forename: Allan Arthur
authors.initials: AA
authors.lastname: Vaag
mesh_terms: D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000150:complications / Q000378:metabolism / Q000401:mortality / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000378:metabolism / Q000401:mortality / Q000517:prevention & control; D058065:Diabetic Cardiomyopathies / Q000378:metabolism / Q000401:mortality / Q000517:prevention & control*; D005947:Glucose / Q000378:metabolism; D005960:Glucosides / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D016032:Randomized Controlled Trials as Topic; D051297:Sodium-Glucose Transporter 2 / Q000378:metabolism; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001559:Benzhydryl Compounds; D002316:Cardiotonic Agents; D005960:Glucosides; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C570240:empagliflozin; D005947:Glucose